Reports for APOTEX INC
Company Name APOTEX INC |
||
---|---|---|
Totals |
||
Shortage reports |
3367 |
|
Actual shortage: | 219 (7%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 10 (0%) | |
Resolved: | 3138 (93%) | |
Discontinuation Reports |
365 |
|
To be discontinued: | 24 (7%) | |
Discontinued: | 341 (93%) | |
Reversed: | 0 (0%) | |
Late reports |
144 (4%) |
|
Overdue reports |
68 (28%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
MIDODRINE | 2.5MG | TABLET | Resolved | 2017-05-11 | 2017-05-17 | 10043 |
MIDODRINE | 2.5MG | TABLET | Resolved | 2017-10-04 | 2017-10-13 | 24363 |
MIDODRINE | 5.0MG | TABLET | Resolved | 2017-10-13 | 2018-12-18 | 25869 |
MIRVALA 21 | 0.1500MG 0.0300MG | TABLET | Resolved | 2018-07-04 | 2018-07-12 | 54312 |
MIRVALA 21 | 0.0300MG 0.1500MG | TABLET | Resolved | 2022-10-21 | 2022-11-07 | 172355 |
MIRVALA 28 | 0.0300MG 0.1500MG | TABLET | Resolved | 2024-08-22 | 2024-10-18 | 235701 |
MIRVALA 28 | 0.1500MG 0.0300MG | TABLET | Resolved | 2019-01-30 | 2019-04-26 | 74028 |
MIRVALA 28 | 0.1500MG 0.0300MG | TABLET | Resolved | 2018-07-04 | 2018-07-12 | 54315 |
MIRVALA 28 | 0.0300MG 0.1500MG | TABLET | Resolved | 2022-01-14 | 2022-01-18 | 152779 |
MYA | 0.02MG 3.00MG | TABLET | Resolved | 2023-12-15 | 2023-12-22 | 213568 |
MYA | 0.02MG 3.00MG | TABLET | Resolved | 2024-03-08 | 2024-03-15 | 221690 |
MYA | 0.02MG 3.00MG | TABLET | Resolved | 2023-05-26 | 2023-06-02 | 193206 |
MYA | 0.02MG 3.00MG | TABLET | Resolved | 2025-02-20 | 2025-02-28 | 250925 |
MYA | 0.02MG 3.00MG | TABLET | Actual shortage | 2025-05-08 | 2025-05-08 | 256899 |
MYA | 3.00MG 0.02MG | TABLET | Resolved | 2017-03-11 | 2020-09-04 | 555 |
MYA | 0.02MG 3.00MG | TABLET | Resolved | 2023-09-22 | 2023-10-06 | 204996 |
ONDANSETRON | 4MG | SOLUTION | Resolved | 2017-03-13 | 2017-03-31 | 2019 |
ONDANSETRON | 4MG | SOLUTION | Resolved | 2017-04-25 | 2018-03-14 | 7880 |
ONDANSETRON | 4MG | SOLUTION | Resolved | 2018-12-19 | 2019-03-21 | 69959 |
ONDANSETRON | 4MG | SOLUTION | Resolved | 2019-04-29 | 2019-08-22 | 82753 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO DIMENHYDRINATE TAB 50MG | 50MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60435 |
APO DIMENHYDRINATE TAB 50MG | 50MG | TABLET | Discontinued | 2018-02-23 | 2018-02-28 | 40835 |
APO FUROSEMIDE TAB 20MG | 20MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60506 |
APO FUROSEMIDE TAB 40MG | 40MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60509 |
APO FUROSEMIDE TAB 80MG | 80MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4719 |
APO GLYBURIDE TAB 2.5MG | 2.5MG | TABLET | Discontinued | 2018-09-07 | 2019-07-04 | 60515 |
APO GLYBURIDE TAB 5MG | 5MG | TABLET | Discontinued | 2018-09-07 | 2018-12-14 | 60518 |
APO HYDRO TAB 100MG | Discontinued | 2019-11-26 | 2019-11-26 | 99653 | ||
APO HYDRO TAB 50MG | 50MG | TABLET | Discontinued | 2018-09-07 | 2019-02-13 | 60521 |
APO IBUPROFEN TAB 300MG | 300MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60527 |
APO IBUPROFEN TAB 300MG | 300MG | TABLET | Discontinued | 2019-01-02 | 2019-01-02 | 70793 |
APO IBUPROFEN TAB 400MG | 400MG | TABLET | Discontinued | 2019-01-02 | 2019-01-02 | 70799 |
APO IBUPROFEN TAB 400MG | 400MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60530 |
APO METOPROLOL (TYPE L) TAB 50MG | 50MG | TABLET | Discontinued | 2018-09-07 | 2019-02-02 | 60634 |
APO METOPROLOL TAB 50MG | 50MG | TABLET | Discontinued | 2018-09-07 | 2019-01-09 | 60631 |
APO NAPROXEN TAB 125MG | 125MG | TABLET | Discontinued | 2018-09-08 | 2019-08-08 | 60663 |
APO NAPROXEN TAB 250MG | 250MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4734 |
APO OXAZEPAM TAB 10MG | 10MG | TABLET | Discontinued | 2018-09-08 | 2019-08-30 | 60675 |
APO OXAZEPAM TAB 15MG | 15MG | TABLET | To be discontinued | 2018-09-08 | 2018-09-08 | 60678 |
APO OXAZEPAM TAB 30MG | 30MG | TABLET | Discontinued | 2018-09-08 | 2019-06-12 | 60681 |